Table 1 Baseline characteristics and Preoperative Findings of Patients with and without Ulinastatin
|  | Control group (n = 200) | Ulinastatin group (n = 100) | P value |
|---|---|---|---|
Age (years) | 62.2 ± 11.5 | 61.8 ± 9.2 | 0.696 |
Sex (male) | 171 (85.5%) | 86 (86.0%) |  > 0.999 |
Hypertension | 127 (63.5%) | 60 (60.0%) | 0.643 |
Diabetes | 85 (45.5%) | 43 (43.0%) |  > 0.999 |
COPD | 2 (1.0%) | 1 (1.0%) |  > 0.999 |
EF | 56.5 ± 14.2 | 56.4 ± 13.9 | 0.981 |
EF < 40% | 30 (15.0%) | 15 (15.0%) |  > 0.999 |
Coronary a | 2.8 ± 0.6 | 2.8 ± 0.5 | 0.601 |
LM coronary a | 74 (37.0%) | 41 (41.0%) | 0.665 |
Hematocrit (%) | 40.4 ± 5.0 | 40.4 ± 4.4 | 0.987 |
Creatinine (mg/dL) | 0.915 ± 0.214 | 0.903 ± 0.200 | 0.638 |